Cargando…

A New Targeted Treatment for Lung Cancer Patients

Detalles Bibliográficos
Autor principal:	Eaby-Sandy, Beth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093309/ https://www.ncbi.nlm.nih.gov/pubmed/25031935

Ejemplares similares

Use of Diagnostic Tests in Advanced Non–Small Cell Lung Cancer
por: Eaby-Sandy, Beth
Publicado: (2017)

Systemic Treatments for Lung Cancer Patients Receiving Hemodialysis
por: Leung, Tzewah V., et al.
Publicado: (2018)

Swelling and Erythema of the Lower Extremities
por: Eaby-Sandy, Beth
Publicado: (2016)

Dermatologic Toxicities in Epidermal Growth Factor Receptor and Multikinase Inhibitors
por: Eaby-Sandy, Beth, et al.
Publicado: (2012)

Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
por: Lacouture, Mario E., et al.
Publicado: (2011)

New targeted treatments for non-small-cell lung cancer – role of nivolumab
por: Zago, Giulia, et al.
Publicado: (2016)

Lung Cancer Biomarker Speak: Teach Me the Language
por: Sandy, Beth, et al.
Publicado: (2022)

Molecularly targeted approaches herald a new era of non-small-cell lung cancer treatment
por: Kaneda, Hiroyasu, et al.
Publicado: (2013)

Neuregulin 1 Gene (NRG1). A Potentially New Targetable Alteration for the Treatment of Lung Cancer
por: Rosas, Daniel, et al.
Publicado: (2021)

Ferroptosis: A New Promising Target for Lung Cancer Therapy
por: Xiong, Rui, et al.
Publicado: (2021)

Targeted Lung Cancer Treatments and Eye Metastasis
por: ZAROGOULIDIS, Paul, et al.
Publicado: (2017)

New Targeted Therapy for Non-Small Cell Lung Cancer
por: Chung, Eun Ki, et al.
Publicado: (2023)

Exploring targeted pulmonary delivery for treatment of lung cancer
por: Goel, Amit, et al.
Publicado: (2013)

Immune checkpoint inhibitors for advanced non-small cell lung cancer: emerging sequencing for new treatment targets
por: Aguiar, Pedro Nazareth, et al.
Publicado: (2017)

Non-Small-Cell Lung Cancer: New Rare Targets—New Targeted Therapies—State of The Art and Future Directions
por: Stencel, Katarzyna, et al.
Publicado: (2021)

Facial Feature Extraction Using a Symmetric Inline Matrix-LBP Variant for Emotion Recognition
por: Babu, Eaby Kollonoor, et al.
Publicado: (2022)

Targeting HER3 for cancer treatment: a new horizon for an old target
por: Uliano, J., et al.
Publicado: (2023)

Role of erlotinib in the targeted treatment of non-small-cell lung cancer in Chinese patients
por: Li, Wei, et al.
Publicado: (2014)

Role of gefitinib in the targeted treatment of non-small-cell lung cancer in Chinese patients
por: Li, Meng-Jiao, et al.
Publicado: (2016)

Tumor Microenvironment: A New Treatment Target for Cancer
por: Tsai, Ming-Ju, et al.
Publicado: (2014)

Targeting the DNA Damage Response Machinery for Lung Cancer Treatment
por: Venugopala, Katharigatta N.
Publicado: (2022)

May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?
por: Psilopatis, Iason, et al.
Publicado: (2022)

Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease
por: Arend, Rebecca C., et al.
Publicado: (2021)

Targeting BRD9 for Cancer Treatment: A New Strategy
por: Zhu, Xiuzuo, et al.
Publicado: (2020)

New insights into the important roles of phase seperation in the targeted therapy of lung cancer
por: Zou, Ying, et al.
Publicado: (2023)

Emerging treatments in lung cancer – targeting the RLIP76 molecular transporter
por: Goldfinger, Lawrence E, et al.
Publicado: (2013)

Targeting FGFR Pathways in Gastrointestinal Cancers: New Frontiers of Treatment
por: Ratti, Margherita, et al.
Publicado: (2023)

Oxidative Stress: A New Target for Pancreatic Cancer Prognosis and Treatment
por: Martinez-Useros, Javier, et al.
Publicado: (2017)

Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer Treatment
por: Bakrania, Anita, et al.
Publicado: (2021)

Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story?
por: Spagnolo, Calogera Claudia, et al.
Publicado: (2023)

Target Therapies in Lung Cancer
por: Bearz, A., et al.
Publicado: (2011)

Advances in cancer treatment: a new therapeutic target, Annexin A2
por: Li, Zinan, et al.
Publicado: (2021)

Targeted Treatments of Bone Metastases in Patients with Lung Cancer
por: Hirsh, Vera
Publicado: (2014)

Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung Cancer
por: Ionescu, Diana N., et al.
Publicado: (2022)

Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer
por: Wesolowski, Robert, et al.
Publicado: (2013)

Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies
por: Chiorean, Elena Gabriela, et al.
Publicado: (2015)

Reconsidering Aromatase for Breast Cancer Treatment: New Roles for an Old Target
por: Caciolla, Jessica, et al.
Publicado: (2020)

Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments
por: Yip, Hon Yan Kelvin, et al.
Publicado: (2021)

Combination of Modern Radiotherapy and New Targeted Treatments for Breast Cancer Management
por: Beddok, Arnaud, et al.
Publicado: (2021)

Targeting Gut Microbiota in Cancer Cachexia: Towards New Treatment Options
por: Panebianco, Concetta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9f5g105pt7kpqhnfk5ogi0flje